These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 17267194

  • 1. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E, Georgarakis E, Sigalas MP, Avgoustakis K, Bikiaris D.
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [Abstract] [Full Text] [Related]

  • 2. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E, Georgarakis M, Docoslis A, Bikiaris D.
    Int J Pharm; 2007 Aug 01; 340(1-2):76-83. PubMed ID: 17478064
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 5. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.
    Karavas E, Georgarakis E, Bikiaris D.
    Int J Pharm; 2006 Apr 26; 313(1-2):189-97. PubMed ID: 16483734
    [Abstract] [Full Text] [Related]

  • 6. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H, Handa T, Alonzo DE, Taylor LS.
    Eur J Pharm Biopharm; 2008 Oct 26; 70(2):493-9. PubMed ID: 18577451
    [Abstract] [Full Text] [Related]

  • 7. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.
    Karavas E, Ktistis G, Xenakis A, Georgarakis E.
    Eur J Pharm Biopharm; 2006 Jun 26; 63(2):103-14. PubMed ID: 16675209
    [Abstract] [Full Text] [Related]

  • 8. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I, Liepold B, Rosenberg J, Maegerlein M, Brandl M, Fricker G.
    Eur J Pharm Sci; 2010 Apr 16; 40(1):25-32. PubMed ID: 20172027
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ, Hinrichs WL, Visser MR, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):220-9. PubMed ID: 16427226
    [Abstract] [Full Text] [Related]

  • 10. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A, Cavallari C, Ospitali F.
    Eur J Pharm Biopharm; 2008 Sep 09; 70(1):409-20. PubMed ID: 18621516
    [Abstract] [Full Text] [Related]

  • 11. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK.
    Eur J Pharm Biopharm; 2006 Oct 09; 64(2):200-5. PubMed ID: 16750355
    [Abstract] [Full Text] [Related]

  • 12. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E, Georgarakis E, Bikiaris D.
    Eur J Pharm Biopharm; 2006 Aug 09; 64(1):115-26. PubMed ID: 16675210
    [Abstract] [Full Text] [Related]

  • 13. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N, Ordu S.
    Farmaco; 1997 Oct 09; 52(10):625-9. PubMed ID: 9507675
    [Abstract] [Full Text] [Related]

  • 14. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
    Papadimitriou S, Bikiaris D.
    Drug Dev Ind Pharm; 2009 Sep 09; 35(9):1128-38. PubMed ID: 19555245
    [Abstract] [Full Text] [Related]

  • 15. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP, Yu BY, Fu GM, Zhu DN.
    J Pharm Biomed Anal; 2005 Jul 01; 38(3):457-64. PubMed ID: 15925247
    [Abstract] [Full Text] [Related]

  • 16. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD, Ju TC, Lee PI.
    Eur J Pharm Biopharm; 2012 May 01; 81(1):149-58. PubMed ID: 22233548
    [Abstract] [Full Text] [Related]

  • 17. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S, Sahu A, Pal K.
    Acta Pol Pharm; 2004 May 01; 61(1):21-30. PubMed ID: 15259854
    [Abstract] [Full Text] [Related]

  • 18. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y, Jones DS, Andrews GP.
    Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM, Jiabi Z.
    Drug Dev Ind Pharm; 1998 May 06; 24(5):455-62. PubMed ID: 9876608
    [Abstract] [Full Text] [Related]

  • 20. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M, Van den Mooter G.
    Eur J Pharm Sci; 2005 Jun 06; 25(2-3):313-20. PubMed ID: 15911228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.